Drug General Information
Drug ID	D0M5EW
Former ID	DNC007302
Drug Name	4-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529860]
Structure		Download 2D MOL 3D MOL
Formula	C13H10N2O2
Canonical SMILES	C1=CC=C2C(=C1)C(=CC(=O)O2)CN3C=CN=C3
InChI	1S/C13H10N2O2/c16-13-7-10(8-15-6-5-14-9-15)11-3-1-2-4-12(11)17-13/h1-7,9H,8H2
InChIKey	SOWQJCOJWDYZNR-UHFFFAOYSA-N
PubChem Compound ID	11276192
Target and Pathway
Target(s)	Cytochrome P450 19	Target Info	Inhibitor	[529860]
BioCyc Pathway	Superpathway of steroid hormone biosynthesis
	Estradiol biosynthesis II
	Estradiol biosynthesis I
KEGG Pathway	Steroid hormone biosynthesis
	Metabolic pathways
	Ovarian steroidogenesis
NetPath Pathway	FSH Signaling Pathway
PANTHER Pathway	Androgen/estrogene/progesterone biosynthesis
PathWhiz Pathway	Androgen and Estrogen Metabolism
Reactome	Endogenous sterols
WikiPathways	Metapathway biotransformation
	Tryptophan metabolism
	Oxidation by Cytochrome P450
	Ovarian Infertility Genes
	Metabolism of steroid hormones and vitamin D
	FSH signaling pathway
	Integrated Breast Cancer Pathway
	Phase 1 - Functionalization of compounds
References
Ref 529860	J Med Chem. 2009 Jan 8;52(1):143-50.Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors.
Ref 529860	J Med Chem. 2009 Jan 8;52(1):143-50.Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.